A Dutch-flagged cruise ship outbreak has killed three people, and South Africa reported identifying an Andes strain in two evacuated victims. But a widely shared claim tying hantavirus infection to Pfizer’s COVID-19 vaccine is misleading: experts say the referenced document doesn’t confirm hantavirus as a vaccine side effect, and the cases are explained by exposure risks instead.
Moderna’s first-quarter revenue topped expectations, powered largely by strong international COVID-19 vaccine sales. While the company expects lower-than-anticipated revenue in Q2, it is betting on longer-term growth, targeting a major slice of Europe’s respiratory vaccine market. Its mCombriax launch is planned for 2027, shifting investor focus beyond COVID.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
